Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.
Consumption of kombucha, a fermented tea beverage, has been promoted for a wide range of health benefits. However, a systematic literature review (Kapp & Sumner, 2019) revealed a lack of evidence for human health benefit. Despite the lack of evidence, U.S. retail sales of kombucha and other fermented beverages have increased 37.4% in 2017, and kombucha is the fastest growing product in the functional beverage market.
As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans. We plan for 20 subjects to take part in this study.
This is a randomized-controlled counter-balanced study design. Subjects will be asked to complete 4 in-person visits over 2 months time (twice per month). At the first visit, subjects will be randomized into one of four groups. At each subsequent visit, subjects will be randomized into one of the remaining groups until they have completed each arm.
Arms (at least 5 subjects in each arm, minimum total=20 subjects)
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention group 1: commercial kombucha | Experimental | 8oz |
|
| Intervention group 2: brewed kombucha | Experimental | 8oz |
|
| Control group 1: tea | Active Comparator | 8oz |
|
| Control group 2: water | Placebo Comparator | 8oz |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Commercial kombucha tea | Dietary Supplement | Commercially-available kombucha tea. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Fasting blood glucose level | Blood drawn following a 10-12 hour fast. | Baseline |
| Fasting insulin level. | Blood drawn following a 10-12 hour fast. | Baseline |
| Blood glucose level | Oral glucose tolerance test | 3 hour |
| Insulin level | Oral glucose tolerance test | 3 hour |
| Measure | Description | Time Frame |
|---|---|---|
| Blood pressure | Baseline |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Currently use any type of nicotine product
A diagnosis of any of the following:
Pregnant or breastfeeding
Prescribed medication for insulin, glucose-lowering drugs, or steroids, such as prednisone
Have routinely taken prebiotic or probiotic supplements in the past 3 months
Have routinely consumed any of the following more than one time per week in the past month: kombucha, kefir, yogurt, kimchi, cottage cheese, raw apple cider vinegar (with the "mother"), sauerkraut, kvass.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Julie M Kapp, MPH, PhD | University of Missouri-Columbia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Missouri | Columbia | Missouri | 65212 | United States |
Not provided
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D006943 | Hyperglycemia |
| ID | Term |
|---|---|
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Brewed kombucha tea | Dietary Supplement | Kombucha tea brewed |
|
| Control: Tea | Other | Tea brewed in our lab. |
|
| Control: Water | Other | Tap water |
|